Instead of funeral  flowers, if you wish, please make a donation to the PMI. Mum was treated and cared for here. Dad also made use of the family accommodation when mum had her 2017 operation at Basingstoke. 

Thank you,

Paul, Tom, Jemma, William, Molly, Emily and Eddie.

The Peritoneal Malignancy Institute (PMI), Basingstoke specialises in the surgical treatment of patients with tumours and cancer that has spread to the peritoneum.

About the PMI charity funds

The Peritoneal Malignancy Institute (PMI) has two charity funds which sit within the main Hampshire Hospitals Charity; the PMI research fund and the C2 ward fund.  The research fund is used for conferences, training and further research into Pseudomyxoma Peritonei.  The ward fund is used to purchase equipment for C2 as well improve facilities within the accommodation.

The Peritoneal Malignancy Institute have secured a Stryker PINPOINT system to aid laparoscopic and open surgery.  The equipment, which will benefit patients undergoing surgery, uses Near Infra-red (NIR) fluorescence and Indocyanine Green (ICG) to help see tissues and peritoneal disease better and allows surgeons to check vascularisation to ensure safer surgeries.  The PINPOINT system uses HD imaging to allow safe and accurate dissection to take place. 

Using money from generous charitable donations the team have been able to purchase two systems which means that the equipment can be used in two surgical theatres at the same time. 

Pseudomyxoma Peritonei

The assessment and management of patients with Pseudomyxoma Peritonei (PMP) has been commissioned from Basingstoke and North Hampshire Hospital, part of Hampshire Hospitals NHS Foundation Trust, since April 2000 and from the Christie Hospital NHS Foundation Trust in Manchester in 2002.

Pseudomyxoma peritonei is a rare malignancy, generally thought to have an incidence of two cases per million per year based on the clinical experience of the Basingstoke and Manchester services, combined with recent epidemiological evidence from Holland.

It is a slowly progressive tumour arising mainly from the appendix (though can originate from the colon, ovaries in women or even more rarely from other intra-abdominal organs) which spreads throughout the peritoneal cavity producing a large amount of mucus. The condition is, at best, borderline malignant but can vary in its aggressiveness and clinical course.